Efficacy of rituximab in gastric diffuse large B cell lymphoma patients

doi:10.3748/wjg.v16.i20.2526

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3945)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

382

HTML

3139

Figures (1-1)

218

Tables (1-4)

206

Sum=3945

May 28, 2010 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 28, 2010; 16(20): 2526-2530
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2526

Open in New Tab Full Size Figure Download Figure

Figure 1 Disease-free survival (DFS) (A) and overall survival (OS) (B) curve. Group A: Cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP); Group B: Rituximab plus chemotherapy.

Citation: Leopardo D, Lorenzo GD, Renzo AD, Federico P, Luponio S, Buonerba C, Matano E, Merola G, Imbimbo M, Montesarchio E, Rea A, Merola MC, Placido SD, Palmieri G. Efficacy of rituximab in gastric diffuse large B cell lymphoma patients. World J Gastroenterol 2010; 16(20): 2526-2530
URL: https://www.wjgnet.com/1007-9327/full/v16/i20/2526.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i20.2526